Multi-drug resistance is rising in urinary E coli, analysis reveals

  28 June 2021

U.S. physicians are having more trouble finding effective first-line antibiotics for common urinary tract infections as antimicrobial resistance rises, a new study suggests.

Investigators calculated the overall prevalence of antimicrobial-resistant Escherichia coli in urine samples from adult and adolescent women between 2011 and 2019. They found that more than a quarter of the E coli from these samples were resistant to trimethoprim-sulfamethoxazole, 21% did not respond well to fluoroquinolones, and 4% did not respond to nitrofurantoin, all antibiotics of choice. 

Fully 6.4% of the tested E coli isolates had evidence of antibiotic-resistant enzymes, 14% were resistant to two or more antibiotics, and 4% were resistant to three or more, reported Keith S. Kaye, M.D., MPH, director of the University of Michigan Medical School’s Division of Infectious Diseases in Ann Arbor, MI.

Further reading: McKnight's
Author(s): Alicia Lasek
Effective Surveillance  


Unrestricted financial support by:


Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre


Ambassador Network

Join the AMR Insights Ambassador Network today!

Connect to over 550 AMR professionals and students in 60 countries!

More information
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!
Popup Plugin